AUD 0.07
(-5.56%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 2.4 Million AUD | -19.32% |
2023 | 2.98 Million AUD | -65.83% |
2022 | 8.72 Million AUD | -25.82% |
2021 | 11.76 Million AUD | 1697.18% |
2020 | 654.81 Thousand AUD | -44.34% |
2019 | 1.17 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 2.4 Million AUD | -19.32% |
2024 Q2 | 1.94 Million AUD | 0.0% |
2024 Q4 | 2.4 Million AUD | 0.0% |
2024 Q3 | 2.4 Million AUD | 23.7% |
2024 Q1 | 1.94 Million AUD | -34.77% |
2023 FY | 2.98 Million AUD | -65.83% |
2023 Q4 | 2.98 Million AUD | 0.0% |
2023 Q3 | 2.98 Million AUD | -46.98% |
2023 Q2 | 5.62 Million AUD | 0.0% |
2023 Q1 | 5.62 Million AUD | -35.56% |
2022 Q2 | 4.92 Million AUD | 0.0% |
2022 FY | 8.72 Million AUD | -25.82% |
2022 Q4 | 8.72 Million AUD | 0.0% |
2022 Q3 | 8.72 Million AUD | 77.08% |
2022 Q1 | 4.92 Million AUD | 179.96% |
2021 Q4 | 1.76 Million AUD | 0.0% |
2021 Q3 | 1.76 Million AUD | 0.0% |
2021 Q1 | - AUD | 0.0% |
2021 FY | 11.76 Million AUD | 1697.18% |
2020 FY | 654.81 Thousand AUD | -44.34% |
2019 FY | 1.17 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Mayne Pharma Group Limited | 1.14 Billion AUD | 99.79% |